Janus Henderson Group PLC Ptc Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$207 Billion
Q3 2025

A detailed history of Janus Henderson Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,773,556 shares of PTCT stock, worth $284 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,773,556

Previous 3,175,015 18.85%

Holding current value

$284 Million

Previous $155 Million 49.34%

% of portfolio

0.11%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.3 - $62.88 $25.9 Million - $37.6 Million	598,541 Added 18.85%	3,773,556 $232 Million
Q2 2025 Aug 14, 2025	BUY	$36.19 - $52.13 $9.35 Million - $13.5 Million	258,286 Added 8.86%	3,175,015 $155 Million
Q1 2025 May 15, 2025	BUY	$41.81 - $57.17 $24.7 Million - $33.8 Million	590,814 Added 25.4%	2,916,729 $149 Million
Q4 2024 Feb 14, 2025	BUY	$34.99 - $52.07 $15.9 Million - $23.7 Million	455,698 Added 24.37%	2,325,915 $105 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $33.8 Million - $41.9 Million	-1,111,342 Reduced 37.27%	1,870,217 $69.4 Million

Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $17 Million - $27.6 Million	-688,257 Reduced 18.75%	2,981,559 $91.2 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $25.5 Million - $33.8 Million	1,057,223 Added 40.47%	3,669,816 $107 Million
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $8.31 Million - $13.5 Million	-459,727 Reduced 14.96%	2,612,593 $72 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $11.8 Million - $22 Million	-524,430 Reduced 14.58%	3,072,320 $68.9 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $16.2 Million - $23.7 Million	400,446 Added 12.53%	3,596,750 $146 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $44.6 Million - $57.1 Million	1,169,162 Added 57.68%	3,196,304 $155 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $1.7 Million - $2.78 Million	-50,722 Reduced 2.44%	2,027,142 $77.4 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $2.42 Million - $3.11 Million	-57,812 Reduced 2.71%	2,077,864 $104 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $14 Million - $24.7 Million	-546,298 Reduced 20.37%	2,135,676 $85.6 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $40.6 Million - $54.4 Million	-1,219,423 Reduced 31.26%	2,681,974 $100 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $11.5 Million - $13.7 Million	326,210 Added 9.12%	3,901,397 $155 Million
Q3 2021 Nov 16, 2021	BUY	$37.01 - $44.74 $2.64 Million - $3.19 Million	71,273 Added 2.03%	3,575,187 $133 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $16.5 Million - $21.5 Million	434,774 Added 14.17%	3,503,914 $148 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $3.4 Million - $5.01 Million	72,719 Added 2.43%	3,069,140 $145 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $46.9 Million - $66.1 Million	977,858 Added 48.44%	2,996,421 $183 Million
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $9.16 Million - $11.5 Million	201,752 Added 11.1%	2,018,563 $94.4 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $2 Million - $2.59 Million	47,054 Added 2.66%	1,816,811 $92.2 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $9.16 Million - $16.8 Million	283,095 Added 19.04%	1,769,757 $78.9 Million
Q4 2019 Feb 18, 2020	BUY	$32.22 - $50.07 $4.3 Million - $6.68 Million	133,357 Added 9.85%	1,486,662 $71.4 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $1.27 Million - $1.81 Million	-37,613 Reduced 2.7%	1,353,305 $45.8 Million
Q2 2019 Jul 31, 2019	SELL	$35.42 - $45.0 $976,210 - $1.24 Million	-27,561 Reduced 1.94%	1,390,918 $62.6 Million
Q1 2019 Apr 30, 2019	BUY	$28.09 - $39.49 $39.8 Million - $56 Million	1,418,479 New	1,418,479 $53.4 Million

Others Institutions Holding PTCT

# of Institutions

325

Shares Held

83.2M

Call Options Held

811K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Ptc Therapeutics, Inc. Transaction History